SynCardia Introduces First in Series of New Internet Patient Education Videos
"The eleven-minute video is narrated by world-renowned heart surgeon Dr. Jack Copeland. "
(EMAILWIRE.COM, March 07, 2008 ) Tucson, Ariz. – As part of a new patient education series that SynCardia Systems, Inc. will launch this summer on its web site, the company has produced a eleven-minute video. It introduces patients to the subject of heart failure and the role of the CardioWest™ temporary Total Artificial Heart (TAH-t). Future additions will include the real life stories of two male and two female patients, ages 28 to 60, as well as artificial heart patients featured in television news.
The eleven-minute video is narrated by world-renowned heart surgeon Dr. Jack Copeland. The video also features CardioWest patient Don Sjolund talking about his artificial heart just three days after receiving his human heart transplant, and the story of award-winning transplant games medalist in swimming, track and cycling, Bill Wohl.
Over the last 23 years, Dr. Copeland and his team at University Medical Center have made major improvements in the treatment of artificial heart patients, including surgical technique, anticoagulation (blood management) and patient care protocols.
There are currently 24 CardioWest certified centers in the U.S. and Europe. These hospitals represent some of the world’s finest heart transplant centers, surgeons and physicians. Six CardioWest hospitals were ranked in U.S. News and World Report’s “2007 Best Heart Hospitals” issue: #1 Cleveland Clinic, #10 Barnes-Jewish Hospital, #19 Hospital University of Pennsylvania, #22 University of Michigan, #29 University Medical Center and #46 University of Maryland.
###
The CardioWest artificial heart is currently approved as a bridge to human heart transplant for patients dying from end stage biventricular failure. These patients are often days, if not hours from death. Their survival depends on receiving a matching donor heart or a CardioWest artificial heart as a bridge to transplant.
In the 10-year pivotal clinical study of the CardioWest artificial heart (New England Journal of Medicine 2004; 351: 859-867), 79 percent of patients receiving the TAH-t survived to transplant. This is the highest bridge to transplant rate for any heart device in the world. There have been more than 700 implants of the CardioWest artificial heart, accounting for more than 120 patient years of life on the artificial heart.
Media Contact:
SynCardia Systems, Inc.
Director of Communications
Don Isaacs
Cell: 520-955-0660
###
This press release was issued through GroupWeb EmailWire.com. For more information on press release distribution, go to http://www.emailwire.com
The eleven-minute video is narrated by world-renowned heart surgeon Dr. Jack Copeland. The video also features CardioWest patient Don Sjolund talking about his artificial heart just three days after receiving his human heart transplant, and the story of award-winning transplant games medalist in swimming, track and cycling, Bill Wohl.
Over the last 23 years, Dr. Copeland and his team at University Medical Center have made major improvements in the treatment of artificial heart patients, including surgical technique, anticoagulation (blood management) and patient care protocols.
There are currently 24 CardioWest certified centers in the U.S. and Europe. These hospitals represent some of the world’s finest heart transplant centers, surgeons and physicians. Six CardioWest hospitals were ranked in U.S. News and World Report’s “2007 Best Heart Hospitals” issue: #1 Cleveland Clinic, #10 Barnes-Jewish Hospital, #19 Hospital University of Pennsylvania, #22 University of Michigan, #29 University Medical Center and #46 University of Maryland.
###
The CardioWest artificial heart is currently approved as a bridge to human heart transplant for patients dying from end stage biventricular failure. These patients are often days, if not hours from death. Their survival depends on receiving a matching donor heart or a CardioWest artificial heart as a bridge to transplant.
In the 10-year pivotal clinical study of the CardioWest artificial heart (New England Journal of Medicine 2004; 351: 859-867), 79 percent of patients receiving the TAH-t survived to transplant. This is the highest bridge to transplant rate for any heart device in the world. There have been more than 700 implants of the CardioWest artificial heart, accounting for more than 120 patient years of life on the artificial heart.
Media Contact:
SynCardia Systems, Inc.
Director of Communications
Don Isaacs
Cell: 520-955-0660
###
This press release was issued through GroupWeb EmailWire.com. For more information on press release distribution, go to http://www.emailwire.com
Contact Information:
SynCardia Systems, Inc
Don Isaacs
Tel: 520-955-0660
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
SynCardia Systems, Inc
Don Isaacs
Tel: 520-955-0660
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
|
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International Equityallianceir.com Penny Stocks to Watch Sign up for hot penny stock picks Gains of 500%+ possible! Premiumstockpicks.com/landing/ Your text Ads & PR Text Ads plus unlimited press releases, One release featured/Day for only $575 per month. Read more on Text Ads & PR Your text Ads Here! Text Ads are only $289 per month. Ads are placed same day. More on Text Ads Advertising |